Cell-free circulating mitochondrial DNA: a potential blood-based marker for atrial fibrillation

Atrial fibrillation (AF) is the most common progressive cardiac tachyarrhythmia globally. AF is present in 3% of the total population, with a higher prevalence in the elderly, and is associated with serious complications such as stroke, heart failure, impaired cognitive function, and increased mortality. Early recognition of AF is essential to prevent disease progression from [...]